Basic Analysis
Analysis | Description | Test Method |
Activity | NLT20000FU/G | UV |
Identity | Nattokinase | FTIR |
Moisture | NMT 10% | Ohaus MB-45 |
Arsenic (As) | < 2 ppm | ICP-MS/AOAC 993.14 |
Cadmium (Cd) | < 2 ppm | ICP-MS/AOAC 993.14 |
Lead (Pb) | < 2 ppm | ICP-MS/AOAC 993.14 |
Mercury (Hg) | < 0.5 ppm | ICP-MS/AOAC 993.14 |
Microbial Analysis |
TPC | <10,000 CFU/g | Soleris / AOAC 990.12 |
E.coli | Negative/10g | Soleris / AOAC 991.14 |
Entero | <100 CFU/g | AOAC 2003.01 |
Salmonella | Negative/25g | BAM Ch. 5 / AOAC 2011.03 |
Yeast | <1,000 CFU/g | Soleris / AOAC 997.02 |
Mold | <1,000 CFU/g | Soleris / AOAC 997.02 |
Coliforms | <100 CFU/g | Soleris / AOAC 991.14 |
Function & Application
Nattokinase (NK for short), also known as subtilisin, is a serine
protease produced by Bacillus subtilisl natto during the fermentation of
natto. It has the functions of dissolving thrombus, reducing blood
viscosity, improving blood circulation, softening and increasing blood
vessel elasticity.
A
significant function of nattokinase is to dissolve thrombus. Mimugu F et
al. used the clot lysis analysis method to determine the fibrinolytic
activity of nattokinase, and compared it with Plasmin, and found that
the fibrinolytic activity of nattokinase was 4 times that of Plasmin;
MiLsugu. F. When nattokinase was injected intravenously into a
chemically induced thrombosis model, it was found that there was obvious
thrombolysis, and it showed a higher fibrinolytic ability than plasmin
and elastase. The above studies indicate that nattokinase exhibits
strong fibrinolytic activity both in vitro and in vivo. Nattokinase can
also activate plasminogen in the body, thereby increasing the amount of
endogenous plasmin. in addition. After oral administration of
nattokinase in healthy people, the following effects appear:
Obviously shorten the dissolution time (ELT) of euglobulin;
Increased fibrinolytic activity in plasma;
The amount of t-PA in plasma has increased. Due to NK's safety,
stability and good thrombolytic effect, it may be used as an oral agent
for thrombosis treatment.